Europe Pharmaceutical Drugs - Innovative Business Models in the Pharmaceutical Industry, Market Share Touch US$ 219.9 Billion by the End of 2027

Europe Pharmaceutical Drugs market analysis

Overview

For treatment of acute and chronic diseases, pharmaceutical drugs are used. These drugs are divided into two categories, branded and generic, which are distributed through OTC (over the counter) and prescription. Generally, branded drugs are identical to generic drugs but are more costly as compared to generic drugs.

*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology. 

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3541

Drivers

Rising incidences of chronic diseases such as cancer, metabolic disorders, and cardiovascular diseases along with expiring patents of branded drugs, launch of products, availability of favorable re-imbursement policies, are all expected to propel growth of the Europe pharmaceutical drugs market over the forecast period.

In 2019, the Europe pharmaceutical drugs market had a valuation of US$ 152.1 billion and is projected to manifest a CAGR of 4.5% during the forecast period (2019-2027).

Emergence of new contagious diseases is expected to aid growth of the Europe pharmaceutical drugs market over the forecast period.

Rising incidences of diabetes and cancer in the European region are expected to fuel demand of the Europe pharmaceutical drugs market during the forecast period. As per the 2019 report from the International Diabetes Foundation, around 59,322 people had diabetes and another 9,500 diabetes patients were diagnosed in Germany.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3541

Furthermore, rising incidences of cancer are expected to augment growth of the Europe pharmaceutical drugs market over the forecast period. As per the 2019 report from the European Commission, around 1.6 million males and another 1.4 million females were diagnosed with cancer in the European nations.

Opportunities

Rising launch of products and increased R&D work are driving growth of the Europe pharmaceutical drugs market.

Rising cancer population had led to increase in demand for effective drug products for treatment of several disorders. Hence, to bode with increasing demand, providers of pharmaceutical drugs are investing in development of products to launch new drugs. In July 2019, Novartis AG’s subsidiary company, Sandoz, had launched a generic oncology drug, Gefitinib for treating adult patients diagnosed with lung cancer across 13 countries of the Europe.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/europe-pharmaceutical-drugs-market-2860

Key Players

Key companies contributing in the Europe pharmaceutical drugs market are Merck KGaA, Baxter AG, Boehringer Ingelheim, Allergan plc., Sanofi, Novo Nordisk, AstraZeneca Plc., F. Hoffmann-La Roche Ltd, Shire, Novartis AG, and GlaxoSmithKline Plc.

Table of Contents

1. Research Objectives and Assumptions
• Research Objectives
• Assumptions
• Abbreviations
2. Market Purview
• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Type
• Market Snippet, By Product Type
• Market Snippet, By Application
• Market Snippet, By Distribution Channel
• Market Snippet, By Country/Region
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Key Developments
• Industry Trends
• Regulatory Scenario
• Reimbursement Scenario
• Epidemiology
• PEST Analysis
4. Europe Pharmaceutical Drugs Market, By Drug Type, 2019 – 2027, (US$ Mn)
• Introduction
• Market Share Analysis, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, 2017 – 2027
• Segment Trends
• Generic Drugs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Branded Drugs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
5. Europe Pharmaceutical Drugs Market, By Product Type, 2019 – 2027, (US$ Mn)
• Introduction
• Market Share Analysis, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, 2017 – 2027
• Segment Trends
• Prescription Drugs
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Over-the-counter (OTC) Drugs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Europe Pharmaceutical Drugs Market, By Application, 2019 – 2027, (US$ Mn)
• Introduction
• Market Share Analysis, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, 2017 – 2027
• Segment Trends
• Cardiovascular
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Musculoskeletal
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Oncology
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Anti-infective
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Metabolic Disorder
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Central Nervous System
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Genito-urinary
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Gastrointestinal
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Respiratory
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Hematology
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Dermatology
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Ophthalmology
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Others
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
7. Europe Pharmaceutical Drugs Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
• Introduction
• Market Share Analysis, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, 2017 – 2027
• Segment Trends
• Hospital Pharmacies
•  Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
8. Europe Pharmaceutical Drugs Market, By Country, 2019 – 2027, (US$ Mn)
• Introduction
• Market Share Analysis, By Region, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, For Regions, 2017–2026
• U.K.
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Germany
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• France
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Italy
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Spain
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Russia
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Netherlands
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Poland
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Switzerland
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Sweden
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
• Rest of Europe
• Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
9. Competitive Landscape
• Company Profiles
10. Section
• References
• Research Methodology
• About us and Sales Contact

Have a Look at Related Research Insights:

VITILIGO DRUGS MARKET ANALYSIS

VIRAL CONJUNCTIVITIS DRUGS MARKET ANALYSIS

FEMALE INFERTILITY TREATMENT DRUGS MARKET ANALYSIS

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837